From Casetext: Smarter Legal Research

United States v. Harris

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK
Mar 5, 2021
18-CR-628 (JMA) (E.D.N.Y. Mar. 5, 2021)

Summary

denying motion for reconsideration where diabetic defendant had received first dose of Moderna vaccine

Summary of this case from United States v. Kosic

Opinion

18-CR-628 (JMA)

03-05-2021

UNITED STATES OF AMERICA, v. DANIEL HARRIS, Defendant.

APPEARANCES: Seth DuCharme Acting United States Attorney Michael R. Maffei Assistant United States Attorney Eastern District of New York 610 Federal Plaza Central Islip, NY 11722 Attorneys for the United States Daniel Harris 91251-053 FCI Danbury Route 37 Danbury, CT 06811 Pro Se Defendant


For Online Publication Only

ORDER APPEARANCES: Seth DuCharme

Acting United States Attorney
Michael R. Maffei

Assistant United States Attorney
Eastern District of New York
610 Federal Plaza
Central Islip, NY 11722

Attorneys for the United States Daniel Harris
91251-053
FCI Danbury
Route 37
Danbury, CT 06811

Pro Se Defendant AZRACK, United States District Judge :

On February 9, 2021, this Court denied the motion of defendant Daniel Harris ("Defendant") in which he sought compassionate release based on the onset of the COVID-19 pandemic. (ECF No. 44.) Ultimately, the Court denied Defendant's motion because he failed to demonstrate "extraordinary and compelling" circumstances warranting compassionate release and the Section 3553(a) sentencing factors weighed against granting his application. (Id.)

Defendant now moves for reconsideration because the Court, repeating a representation in the Government's opposition brief, observed that "he is under evaluation for diabetes." (Id. at 4.) Though Defendant never made mention of diabetes in his original motion, he now argues that he actually does have Type II diabetes. (ECF No. 46 at 3.) He argues that this diagnosis, combined with his other medical conditions the Court previously analyzed, entitles him to compassionate release because he faces a higher likelihood of complications should he contract COVID-19. (Id.) Defendant also reiterates his prior arguments regarding application of the Section 3553(a) factors. (Id. at 5.)

"The standards for reconsideration among the civil and criminal rules are largely the same." United States v. Daugerdas, No. 9-CR-581, 2020 WL 4931988, at *2 (S.D.N.Y. Aug. 18, 2020) (quoting United States v. Lisi, 2020 WL 1331955, at *2 (S.D.N.Y. Mar. 23, 2020)). "The standard for granting such a motion is strict, and reconsideration will generally be denied unless the moving party can point to controlling decisions or data that the court overlooked—matters, in other words, that might reasonably be expected to alter the conclusion reached by the court." Glob. View Ltd. Venture Capital v. Great Cent. Basin Expl., L.L.C., 288 F. Supp. 2d 482, 483 (S.D.N.Y. 2003) (quoting Shrader v. CSX Transp., Inc., 70 F.3d 255, 257 (2d Cir. 1995)).

In assessing Defendant's original motion, the Court was aware that Defendant may have been diabetic and assessed his motion accordingly. Knowing that he is, in fact, diabetic does not alter the Court's prior analysis and does not change the conclusion the Court reached. Furthermore, the Government has informed the Court that Defendant has received his first dose of the Moderna vaccine. (ECF No. 48.) Based on distribution patterns, it is likely that he received the vaccine more quickly in prison than he would have outside of it. See United States v. Mckay, No. 18-CR-339, 2021 WL 807108, at *4 (S.D.N.Y. Mar. 3, 2021). Though the Court is sympathetic to Defendant's medical conditions, it is by no means certain Defendant will contract COVID-19, particularly in light of: (1) his vaccination; (2) the protective measures the BOP has taken to curb spread of the disease; and (3) the fact that only one inmate is currently testing positive for COVID-19 at his facility. For these reasons and those articulated in more detail in the Court's prior order, (ECF No 44), which the Court incorporates by reference, Defendant's motion is DENIED.

As of March 5, 2021, the number of inmates at FCI Danbury testing positive for COVID-19 is 1 and the number of staff testing positive for COVID-19 is 1. See Federal Bureau of Prisons, COVID-19 Cases, www.bop.gov/coronavirus (providing daily calculations of confirmed infections) (accessed on March 5, 2021, at 9:00 a m.). --------

SO ORDERED.

Dated: March 5, 2021

Central Islip, New York

/s/ (JMA)

JOAN M. AZRACK

UNITED STATES DISTRICT JUDGE


Summaries of

United States v. Harris

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK
Mar 5, 2021
18-CR-628 (JMA) (E.D.N.Y. Mar. 5, 2021)

denying motion for reconsideration where diabetic defendant had received first dose of Moderna vaccine

Summary of this case from United States v. Kosic
Case details for

United States v. Harris

Case Details

Full title:UNITED STATES OF AMERICA, v. DANIEL HARRIS, Defendant.

Court:UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK

Date published: Mar 5, 2021

Citations

18-CR-628 (JMA) (E.D.N.Y. Mar. 5, 2021)

Citing Cases

United States v. Whaley

“‘The standards for reconsideration among the civil and criminal rules are largely the same.'” United States…

United States v. Parker

“Indeed, courts in this circuit have found that vaccination mitigates the risk an inmate faces from COVID-19…